市场见解

Sonic (ASX:SHL) share price in the spotlight as it posts a 166% profit surge

The Sonic Healthcare Limited (ASX: SHL) could be poised to outperform the market today after it posted a more than doubling in net profit this morning.
The post Sonic (ASX:SHL) share price in the spotlight as it posts a 166% profit surge appeared first on The Motley Fool Australia. –

Health technology shares sonic share price profit results

The Sonic Healthcare Limited (ASX: SHL) could be poised to outperform the market today after it posted a more than doubling in net profit this morning.

But the big increase in profit and revenue isn’t the most exciting part of the result, although it will still be warmly welcomed by shareholders.

The medical diagnostic services group posted a 166% surge in first half net profit to $678 million. Earnings before interest, tax, depreciation and amortisation (EBITDA) jumped 89% to $1.3 billion as revenue improved by a third to $4.4 billion.

Sonic share price gets COVID profit booster shot

The Sonic share price has been a COVID-19 winner as demand for COVID tests have hit the roof in all the countries it operates in.

Sonic undertook more than 18 million PCR tests to date in around 60 Sonic laboratories located around the world.

Demand for such tests is likely to persist for a while yet. Even as mass vaccinations are rolled out globally, testing is key to controlling the spread.

Other tailwinds behind Sonic’s share price  

But a bigger reason why I like its results is the operating leverage. Earnings have increased significantly ahead of revenue due to economies of scale.

Another exciting detail relates to its core business of testing and screening for non-COVID ailments. This part of the business took a big hit at the start of the pandemic due to social restrictions and patients fear of catching COVID at medical facilities.

“Our global base business revenue (excluding COVID testing) declined by 1% versus the comparative period, which was a very significant improvement versus the dramatic falls in base business we experienced from mid-March through May 2020,” said Sonic’s CEO, Dr Colin Goldschmidt.

“It appears our base business is becoming increasingly less affected by social restrictions and fear of infection, through better community understanding of the dangers in delaying or avoiding essential healthcare services.”

New growth opportunities

Sonic upped its interim dividend by 6%, or 2 cents, to 36 cents a share and the group’s gearing hit a record low. Sonic has $1.3 billion in liquidity before paying out the first half dividend.

That should still leave plenty in the tank to grow the business, and on that front, Sonic is striking an upbeat tone.

“Our management teams around the world are increasingly focussing on further growth opportunities, including acquisitions, contracts and joint ventures, supported by our very strong balance sheet,” added Goldschmidt.

“We are currently bidding on significant opportunities in Australia, the UK, the USA and Alberta, Canada.”

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. Connect with me on Twitter @brenlau.

The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Sonic (ASX:SHL) share price in the spotlight as it posts a 166% profit surge appeared first on The Motley Fool Australia.

随时随地,交易世界!

移动APP平台,拥有 12 个市场的 50,000 多种全球上市证券(全球市值超过 70%),直接在您的 Android 或 iOS 设备上即可操作。

与独有的交易理念和投资分析工具相结合,帮助您在我们 12 个全球市场中的几乎所有金融工具上找到可操作的见解,从而帮助您优化交易策略。

推荐给您的朋友

向您的朋友推荐Monex并赠予他们免费使用我们交易工具的机会

我们尊重您的隐私,只会向您的朋友发送一封邮件 

与您的朋友分享

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!